Evaluation of the quality of life-enhancing effect of allogeneic feline adipose mesenchymal stem cells in cats with osteoarthritis: A pilot study
Osteoarthritis (OA) is a progressive degenerative disease in older cats, and often leads to decreased quality of life (QOL). Mesenchymal stem cells (MSCs) have been used in novel therapies for inflammatory diseases. We aimed to evaluate quantitatively allogeneic adipose-derived MSC (ADSC) therapy in...
Gespeichert in:
| Veröffentlicht in: | Research in veterinary science 2025-01, Vol.182, p.105470, Article 105470 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | 105470 |
| container_title | Research in veterinary science |
| container_volume | 182 |
| creator | Mitani, Kosuke Ito, Yuki Takene, Yukio Inaba, Toshio |
| description | Osteoarthritis (OA) is a progressive degenerative disease in older cats, and often leads to decreased quality of life (QOL). Mesenchymal stem cells (MSCs) have been used in novel therapies for inflammatory diseases. We aimed to evaluate quantitatively allogeneic adipose-derived MSC (ADSC) therapy in cats with naturally occurring OA, based on QOL assessment resources. To characterize the in vitro properties of ADSCs, we estimated ADSCs from four healthy cats with respect to morphology, differentiation potential, and immunomodulatory potential. Six cats with OA were administered a single intravenous injection of allogeneic ADSCs. Based on the feline musculoskeletal pain index (FMPI), the outcome measure was QOL. The cultured cells were adherent, exhibited a spindle shape without becoming flattened or large, and maintained doubling time until passage 5. After induction, the cells had osteogenic, adipogenic, and chondrogenic phenotypes. These cells expressed CD44 and CD90 and lacked expression of CD14 and CD45, had significantly suppressed the production of interferon -ɤ released from mitogen-stimulated lymphocytes (P |
| doi_str_mv | 10.1016/j.rvsc.2024.105470 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3154250698</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0034528824003370</els_id><sourcerecordid>3154250698</sourcerecordid><originalsourceid>FETCH-LOGICAL-c270t-490b67f3f546071702601bfb19bac2909964fa3f9a4d21fcf5c26cc7702235973</originalsourceid><addsrcrecordid>eNqNkc9u1DAQhy0EotvCC3BAPnLJ4n9xEsSlqgpFqsSlPVuOM268cuKt7Wy1j9E3rqMtHBGnkWe--cmaD6FPlGwpofLrbhsPyWwZYaI0atGQN2hDa84qJiV9izaEcFHVrG3P0HlKO0KIoLR5j854JylreLtBz9cH7RedXZhxsDiPgB8X7V0-rk_vLFQwj3o2bn7AYC2YvA609-EBZnAGW_BuBqwHtw8J8AQJZjMeJ-1xyjBhA94n7GZsdE74yeURhzIIOuYxuuzSN3yJ986HXPhlOH5A76z2CT6-1gt0_-P67uqmuv3989fV5W1lWENyJTrSy8ZyWwtJGtoQJgntbU-7XhvWka6TwmpuOy0GRq2xtWHSmKaAjNddwy_Ql1PuPobHBVJWk0vrZ_UMYUmK01qwmsiu_Q-UC85J266p7ISaGFKKYNU-uknHo6JErdbUTq3W1GpNnayVpc-v-Us_wfB35Y-mAnw_AVAOcnAQVTKunBkGF4sRNQT3r_wXdJiqDQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3134330887</pqid></control><display><type>article</type><title>Evaluation of the quality of life-enhancing effect of allogeneic feline adipose mesenchymal stem cells in cats with osteoarthritis: A pilot study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Mitani, Kosuke ; Ito, Yuki ; Takene, Yukio ; Inaba, Toshio</creator><creatorcontrib>Mitani, Kosuke ; Ito, Yuki ; Takene, Yukio ; Inaba, Toshio</creatorcontrib><description>Osteoarthritis (OA) is a progressive degenerative disease in older cats, and often leads to decreased quality of life (QOL). Mesenchymal stem cells (MSCs) have been used in novel therapies for inflammatory diseases. We aimed to evaluate quantitatively allogeneic adipose-derived MSC (ADSC) therapy in cats with naturally occurring OA, based on QOL assessment resources. To characterize the in vitro properties of ADSCs, we estimated ADSCs from four healthy cats with respect to morphology, differentiation potential, and immunomodulatory potential. Six cats with OA were administered a single intravenous injection of allogeneic ADSCs. Based on the feline musculoskeletal pain index (FMPI), the outcome measure was QOL. The cultured cells were adherent, exhibited a spindle shape without becoming flattened or large, and maintained doubling time until passage 5. After induction, the cells had osteogenic, adipogenic, and chondrogenic phenotypes. These cells expressed CD44 and CD90 and lacked expression of CD14 and CD45, had significantly suppressed the production of interferon -ɤ released from mitogen-stimulated lymphocytes (P < 0.05). The FMPI of all cats with OA significantly increased one month after ADSC therapy (P < 0.05). No adverse effects associated with ADSC administration were observed during follow-up in any of the cats. In conclusion, ADSC therapy with immunomodulatory potential could have beneficial effects on the QOL in cats with OA. Further research is necessary to carry out larger studies of the effectiveness of ADSC therapy.
•Common in older cats, osteoarthritis often leads to a decline in quality of life.•Adipose-derived mesenchymal stem cells have immunomodulatory potential.•Regenerative therapy could be beneficial for cats with osteoarthritis.•No adverse effects related to the therapy were observed during follow-up.</description><identifier>ISSN: 0034-5288</identifier><identifier>ISSN: 1532-2661</identifier><identifier>EISSN: 1532-2661</identifier><identifier>DOI: 10.1016/j.rvsc.2024.105470</identifier><identifier>PMID: 39612738</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adipose Tissue - cytology ; Animals ; bone formation ; Cat Diseases - therapy ; Cats ; Feline ; Female ; interferons ; intravenous injection ; Male ; Mesenchymal stem cell therapy ; Mesenchymal Stem Cell Transplantation - veterinary ; Mesenchymal Stem Cells ; musculoskeletal system ; Osteoarthritis ; Osteoarthritis - therapy ; Osteoarthritis - veterinary ; pain ; Pilot Projects ; Quality of Life ; veterinary medicine</subject><ispartof>Research in veterinary science, 2025-01, Vol.182, p.105470, Article 105470</ispartof><rights>2024 Elsevier Ltd</rights><rights>Copyright © 2024 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c270t-490b67f3f546071702601bfb19bac2909964fa3f9a4d21fcf5c26cc7702235973</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0034528824003370$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39612738$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mitani, Kosuke</creatorcontrib><creatorcontrib>Ito, Yuki</creatorcontrib><creatorcontrib>Takene, Yukio</creatorcontrib><creatorcontrib>Inaba, Toshio</creatorcontrib><title>Evaluation of the quality of life-enhancing effect of allogeneic feline adipose mesenchymal stem cells in cats with osteoarthritis: A pilot study</title><title>Research in veterinary science</title><addtitle>Res Vet Sci</addtitle><description>Osteoarthritis (OA) is a progressive degenerative disease in older cats, and often leads to decreased quality of life (QOL). Mesenchymal stem cells (MSCs) have been used in novel therapies for inflammatory diseases. We aimed to evaluate quantitatively allogeneic adipose-derived MSC (ADSC) therapy in cats with naturally occurring OA, based on QOL assessment resources. To characterize the in vitro properties of ADSCs, we estimated ADSCs from four healthy cats with respect to morphology, differentiation potential, and immunomodulatory potential. Six cats with OA were administered a single intravenous injection of allogeneic ADSCs. Based on the feline musculoskeletal pain index (FMPI), the outcome measure was QOL. The cultured cells were adherent, exhibited a spindle shape without becoming flattened or large, and maintained doubling time until passage 5. After induction, the cells had osteogenic, adipogenic, and chondrogenic phenotypes. These cells expressed CD44 and CD90 and lacked expression of CD14 and CD45, had significantly suppressed the production of interferon -ɤ released from mitogen-stimulated lymphocytes (P < 0.05). The FMPI of all cats with OA significantly increased one month after ADSC therapy (P < 0.05). No adverse effects associated with ADSC administration were observed during follow-up in any of the cats. In conclusion, ADSC therapy with immunomodulatory potential could have beneficial effects on the QOL in cats with OA. Further research is necessary to carry out larger studies of the effectiveness of ADSC therapy.
•Common in older cats, osteoarthritis often leads to a decline in quality of life.•Adipose-derived mesenchymal stem cells have immunomodulatory potential.•Regenerative therapy could be beneficial for cats with osteoarthritis.•No adverse effects related to the therapy were observed during follow-up.</description><subject>Adipose Tissue - cytology</subject><subject>Animals</subject><subject>bone formation</subject><subject>Cat Diseases - therapy</subject><subject>Cats</subject><subject>Feline</subject><subject>Female</subject><subject>interferons</subject><subject>intravenous injection</subject><subject>Male</subject><subject>Mesenchymal stem cell therapy</subject><subject>Mesenchymal Stem Cell Transplantation - veterinary</subject><subject>Mesenchymal Stem Cells</subject><subject>musculoskeletal system</subject><subject>Osteoarthritis</subject><subject>Osteoarthritis - therapy</subject><subject>Osteoarthritis - veterinary</subject><subject>pain</subject><subject>Pilot Projects</subject><subject>Quality of Life</subject><subject>veterinary medicine</subject><issn>0034-5288</issn><issn>1532-2661</issn><issn>1532-2661</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc9u1DAQhy0EotvCC3BAPnLJ4n9xEsSlqgpFqsSlPVuOM268cuKt7Wy1j9E3rqMtHBGnkWe--cmaD6FPlGwpofLrbhsPyWwZYaI0atGQN2hDa84qJiV9izaEcFHVrG3P0HlKO0KIoLR5j854JylreLtBz9cH7RedXZhxsDiPgB8X7V0-rk_vLFQwj3o2bn7AYC2YvA609-EBZnAGW_BuBqwHtw8J8AQJZjMeJ-1xyjBhA94n7GZsdE74yeURhzIIOuYxuuzSN3yJ986HXPhlOH5A76z2CT6-1gt0_-P67uqmuv3989fV5W1lWENyJTrSy8ZyWwtJGtoQJgntbU-7XhvWka6TwmpuOy0GRq2xtWHSmKaAjNddwy_Ql1PuPobHBVJWk0vrZ_UMYUmK01qwmsiu_Q-UC85J266p7ISaGFKKYNU-uknHo6JErdbUTq3W1GpNnayVpc-v-Us_wfB35Y-mAnw_AVAOcnAQVTKunBkGF4sRNQT3r_wXdJiqDQ</recordid><startdate>202501</startdate><enddate>202501</enddate><creator>Mitani, Kosuke</creator><creator>Ito, Yuki</creator><creator>Takene, Yukio</creator><creator>Inaba, Toshio</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope></search><sort><creationdate>202501</creationdate><title>Evaluation of the quality of life-enhancing effect of allogeneic feline adipose mesenchymal stem cells in cats with osteoarthritis: A pilot study</title><author>Mitani, Kosuke ; Ito, Yuki ; Takene, Yukio ; Inaba, Toshio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c270t-490b67f3f546071702601bfb19bac2909964fa3f9a4d21fcf5c26cc7702235973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Adipose Tissue - cytology</topic><topic>Animals</topic><topic>bone formation</topic><topic>Cat Diseases - therapy</topic><topic>Cats</topic><topic>Feline</topic><topic>Female</topic><topic>interferons</topic><topic>intravenous injection</topic><topic>Male</topic><topic>Mesenchymal stem cell therapy</topic><topic>Mesenchymal Stem Cell Transplantation - veterinary</topic><topic>Mesenchymal Stem Cells</topic><topic>musculoskeletal system</topic><topic>Osteoarthritis</topic><topic>Osteoarthritis - therapy</topic><topic>Osteoarthritis - veterinary</topic><topic>pain</topic><topic>Pilot Projects</topic><topic>Quality of Life</topic><topic>veterinary medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mitani, Kosuke</creatorcontrib><creatorcontrib>Ito, Yuki</creatorcontrib><creatorcontrib>Takene, Yukio</creatorcontrib><creatorcontrib>Inaba, Toshio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>Research in veterinary science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mitani, Kosuke</au><au>Ito, Yuki</au><au>Takene, Yukio</au><au>Inaba, Toshio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of the quality of life-enhancing effect of allogeneic feline adipose mesenchymal stem cells in cats with osteoarthritis: A pilot study</atitle><jtitle>Research in veterinary science</jtitle><addtitle>Res Vet Sci</addtitle><date>2025-01</date><risdate>2025</risdate><volume>182</volume><spage>105470</spage><pages>105470-</pages><artnum>105470</artnum><issn>0034-5288</issn><issn>1532-2661</issn><eissn>1532-2661</eissn><abstract>Osteoarthritis (OA) is a progressive degenerative disease in older cats, and often leads to decreased quality of life (QOL). Mesenchymal stem cells (MSCs) have been used in novel therapies for inflammatory diseases. We aimed to evaluate quantitatively allogeneic adipose-derived MSC (ADSC) therapy in cats with naturally occurring OA, based on QOL assessment resources. To characterize the in vitro properties of ADSCs, we estimated ADSCs from four healthy cats with respect to morphology, differentiation potential, and immunomodulatory potential. Six cats with OA were administered a single intravenous injection of allogeneic ADSCs. Based on the feline musculoskeletal pain index (FMPI), the outcome measure was QOL. The cultured cells were adherent, exhibited a spindle shape without becoming flattened or large, and maintained doubling time until passage 5. After induction, the cells had osteogenic, adipogenic, and chondrogenic phenotypes. These cells expressed CD44 and CD90 and lacked expression of CD14 and CD45, had significantly suppressed the production of interferon -ɤ released from mitogen-stimulated lymphocytes (P < 0.05). The FMPI of all cats with OA significantly increased one month after ADSC therapy (P < 0.05). No adverse effects associated with ADSC administration were observed during follow-up in any of the cats. In conclusion, ADSC therapy with immunomodulatory potential could have beneficial effects on the QOL in cats with OA. Further research is necessary to carry out larger studies of the effectiveness of ADSC therapy.
•Common in older cats, osteoarthritis often leads to a decline in quality of life.•Adipose-derived mesenchymal stem cells have immunomodulatory potential.•Regenerative therapy could be beneficial for cats with osteoarthritis.•No adverse effects related to the therapy were observed during follow-up.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>39612738</pmid><doi>10.1016/j.rvsc.2024.105470</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0034-5288 |
| ispartof | Research in veterinary science, 2025-01, Vol.182, p.105470, Article 105470 |
| issn | 0034-5288 1532-2661 1532-2661 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3154250698 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adipose Tissue - cytology Animals bone formation Cat Diseases - therapy Cats Feline Female interferons intravenous injection Male Mesenchymal stem cell therapy Mesenchymal Stem Cell Transplantation - veterinary Mesenchymal Stem Cells musculoskeletal system Osteoarthritis Osteoarthritis - therapy Osteoarthritis - veterinary pain Pilot Projects Quality of Life veterinary medicine |
| title | Evaluation of the quality of life-enhancing effect of allogeneic feline adipose mesenchymal stem cells in cats with osteoarthritis: A pilot study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T08%3A07%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20the%20quality%20of%20life-enhancing%20effect%20of%20allogeneic%20feline%20adipose%20mesenchymal%20stem%20cells%20in%20cats%20with%20osteoarthritis:%20A%20pilot%20study&rft.jtitle=Research%20in%20veterinary%20science&rft.au=Mitani,%20Kosuke&rft.date=2025-01&rft.volume=182&rft.spage=105470&rft.pages=105470-&rft.artnum=105470&rft.issn=0034-5288&rft.eissn=1532-2661&rft_id=info:doi/10.1016/j.rvsc.2024.105470&rft_dat=%3Cproquest_cross%3E3154250698%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3134330887&rft_id=info:pmid/39612738&rft_els_id=S0034528824003370&rfr_iscdi=true |